Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
about
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatmentThe neurobiological link between OCD and ADHDThe aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake.Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.Relationship between the serotonin transporter polymorphism and obsessive-compulsive alcohol craving in alcohol-dependent adults: a pilot studyAVPR1A and SLC6A4 polymorphisms in choral singers and non-musicians: a gene association study.Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes.Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive-compulsive disorder.Association of serotonin transporter gene polymorphisms with obsessive-compulsive disorder (OCD) in a south Indian populationAssociation between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample.Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthoodObsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts.Dopamine D4 receptor and serotonin transporter gene effects on the longitudinal development of infant temperament.Genetic factors modulating the response to stimulant drugs in humans.Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneityBrain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.Polymorphism in serotonin receptor 3B is associated with pain catastrophizing.Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study.Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential.A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients.Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.Pharmacogenetics of obsessive-compulsive disorders.Pharmacogenetically driven treatments for alcoholism: are we there yet?An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis.Tourette's syndrome and associated disorders: a systematic review.The Impact of Genetics on Physical Resilience and Successful Aging.Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility.Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies.Peripheral SLC6A4 Gene Expression in Obsessive-Compulsive Disorder in the Han Chinese PopulationObsessive-compulsive disorder and 5-HTTLPR.Direct, indirect and pleiotropic effects of candidate genes on internalizing disorder psychopathology.Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study.High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.Nonparametric tests of associations with disease based on U-statistics.Serotonin transporter promoter polymorphism is associated with executive function impairments in patients with obsessive compulsive disorder.Stressful life events at onset of obsessive-compulsive disorder are associated with a distinct clinical pattern.
P2860
Q24633004-C57AA6F3-5A67-4197-A9A3-75D940136746Q27002629-00C65A0A-3C33-4044-A5AD-37D2FA69052DQ28391257-677D822F-54C5-4B26-80F6-EB882A1DABD9Q30432894-23760CAC-A3FF-49AA-90FE-EB6E9290B473Q34020568-7E959BB3-FC51-4E41-820A-BD58B38E3B23Q34101553-A03F84AA-941F-4B2C-AA6D-9DC096476256Q34181944-7E7D99C0-6F58-4AF3-A3CF-9F1B0C0FD6A3Q34188761-B9893776-61CD-4AFF-98B2-F5E7E41CDBAFQ34206852-DB032F2E-7D45-4246-81C5-AD97CF5988CCQ35008576-13BB2493-5394-4217-A8BF-471ACB1FAA62Q35083877-5F26F151-DEC5-4826-B6B3-99BEC9E235AAQ35097990-4E5564B0-DF18-43E9-90BC-5FE2A9481BCEQ35237204-E08315DC-F4D5-4457-A1CE-1479FC83C2EAQ35748928-5E558197-9AA7-4569-9030-1BA0E48DA683Q36071808-27FE75DC-EACC-4EB5-A048-457447C0C39EQ36367301-D9637494-FC73-474C-B9EF-24A5EC459A98Q36801195-1088CCAC-F8B5-43B0-AAC5-E50AFD2EF5FEQ36916929-90246D24-1C20-4C99-9DBB-91906D4935D6Q37026324-13407CDE-D582-48FC-9C4D-141DE200581DQ37297649-8F7440C0-A3F9-4217-8705-C9E4CFDE7387Q37474677-43AB1B7F-F0C5-42DF-9604-B74C8DE52CE2Q37578478-04898BA0-B4C7-4C33-92E9-F11FD0B4971FQ37637018-E2FF52BD-D682-412C-B6C7-8D2C176AA289Q37661412-F5B7703C-75D6-4B55-ABF8-D3C123E89526Q37969219-0D3000CE-2960-4C7E-824B-51192000E6F0Q38010250-D53C9BCF-8631-4721-ABCE-D57DE77C8F7CQ38207094-62BC77ED-5DEF-493A-8464-304D79878289Q38431816-BC5AF835-AC2B-4A20-8F95-DB62E416322CQ38785107-FC1CC215-80F0-47E0-A4C0-76FABAA8525EQ39275571-E0AEFDF3-0D01-43E0-8073-03FF52D2B7DDQ39292063-C7161275-3FCB-49D2-9898-B5428C056DCDQ39607970-C1CA98FB-A869-4823-ACA7-08DC75DB8281Q41582905-24779D09-C636-4684-ADA6-88176288F6C4Q43270512-2775F1A4-7C64-45DB-90B0-363DB94E7592Q45009641-DC301C7A-392B-4135-9EFC-E6F61D0B368EQ45974051-487390D2-ED51-42B8-A954-600BAD06369CQ46067196-F890CF8D-2558-48CF-858E-98BAC68A26A5Q48907007-EA2E17EA-084C-4990-A1CB-E010008710A6Q50537467-E3794243-C7AD-4309-A95F-0FE121C24FAAQ51814991-E519EC3F-69EA-42D9-8306-02A4D33F64AE
P2860
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of the serotonin t ...... e disorder: systematic review.
@en
Association of the serotonin t ...... e disorder: systematic review.
@nl
type
label
Association of the serotonin t ...... e disorder: systematic review.
@en
Association of the serotonin t ...... e disorder: systematic review.
@nl
prefLabel
Association of the serotonin t ...... e disorder: systematic review.
@en
Association of the serotonin t ...... e disorder: systematic review.
@nl
P2093
P2860
P356
P1476
Association of the serotonin t ...... e disorder: systematic review.
@en
P2093
Angeli Landeros-Weisenberger
Ben Kelmendi
James F Leckman
Michael H Bloch
Philip Dombrowski
Srijan Sen
Vladimir Coric
P2860
P304
P356
10.1002/AJMG.B.30699
P577
2008-09-01T00:00:00Z